Correction: Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
我要评论
本文译者
- 译文：0 篇
本期排行
- RNA-based high-risk HPV genoty...
- Correction: Mapping the bindin...
- Recurrent KRAS mutations ident...
- Prognostic stratification of c...
- Mapping the binding sites of a...
- MYCN RNA levels determined by ...
- Immune subtyping of extranodal...
- Two types of primary mucinous ...
- Metaplastic thymoma: a distinc...
- Sclerosing sialadenitis of the...
共0条评论